Home › NDC Lookup › RxCUI directory › RxCUI 1085752

Triamcinolone acetonide 10 MG/ML Injectable Suspension [Kenalog] — RxCUI 1085752

Name: Triamcinolone acetonide 10 MG/ML Injectable Suspension [Kenalog] (RxCUI 1085752)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1085752 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1085752

Official nameTriamcinolone acetonide 10 MG/ML Injectable Suspension [Kenalog]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asKenalog 10 MG/ML Injectable Suspension; Kenalog-10 10 MG/ML Injectable Suspension

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)240,358 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triamcinolone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It depends on the product. Injections treat severe allergic conditions, joint inflammation, certain skin problems and eye inflammation. Creams and ointments calm itchy, inflamed sk...
Injections are given by a healthcare professional. Ointment is applied as a thin film to the affected area two to three times daily. Nasal spray bottles need priming before first u...
Possible effects include injection site pain, joint swelling, headache, muscle spasms, cough, sinusitis and bruising. People with diabetes may see higher blood sugar. Tell your doc...
Call right away for signs of an allergic reaction, fever or infection, a very painful and swollen joint, vision changes, or mood changes. Also report black stools, severe stomach p...

📖 Read our full Triamcinolone guide →

🕸️ Concept Web — How Triamcinolone acetonide 10 MG/ML Injectable Susp... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Triamcinolone acetonide 10 MG/ML Injectable Suspension [Kenalog] RxCUI 1085752 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Triamcinolone 10759 IN
- Triamcinolone acetonide 10761 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Kenalog 202877 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Triamcinolone Injectable Suspension 96818 SCDF
- Triamcinolone acetonide Injectable Suspension 2647028 SCDFP
- Triamcinolone Injectable Product 1158224 SCDG
- Triamcinolone acetonide Injectable Product 2663063 SCDGP
- Triamcinolone Injectable Suspension [Kenalog] 365675 SBDF
- Triamcinolone acetonide Injectable Suspension [Kenalog] 2656117 SBDFP
- Kenalog Injectable Product 1170041 SBDG
- Injectable Suspension 316950 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Triamcinolone acetonide 10 MG/ML Injectable Suspension 1085750 SCD
- Triamcinolone acetonide 10 MG/ML 1085749 SCDC
- Triamcinolone acetonide 10 MG/ML [Kenalog] 1085751 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Triamcinolone acetonide 10 MG/ML Injectable Suspension SCD · 1085750
Triamcinolone acetonide 10 MG/ML SCDC · 1085749
Triamcinolone Injectable Suspension SCDF · 96818
Triamcinolone acetonide Injectable Suspension SCDFP · 2647028
Triamcinolone Injectable Product SCDG · 1158224
Triamcinolone acetonide Injectable Product SCDGP · 2663063

Brand-Name Concepts

Triamcinolone acetonide 10 MG/ML [Kenalog] SBDC · 1085751
Triamcinolone Injectable Suspension [Kenalog] SBDF · 365675
Triamcinolone acetonide Injectable Suspension [Kenalog] SBDFP · 2656117
Kenalog Injectable Product SBDG · 1170041
Kenalog BN · 202877

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1085752 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00003-0494-20	1 VIAL, MULTI-DOSE in 1 CARTON (0003-0494-20) / 5 mL in 1 V...	KENALOG-10	E.R. Squibb & Sons, L.L.C.	2009-06-01
50090-0295-01	1 VIAL, MULTI-DOSE in 1 CARTON (50090-0295-1) / 5 mL in 1 V...	KENALOG-10	A-S Medication Solutions	2016-06-29

Observed labelers: A-S Medication Solutions (1) · E.R. Squibb & Sons, L.L.C. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ml · median

$2.3230

Range $2.3230–$2.3230 · middle 50% $2.3230–$2.3230 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3301	Triamcinolone acet inj nos	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.